Toy Andrew sold $1.7M of CLOV
Toy Andrew (Chief Executive Officer) sold 313,476 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) at $5.32 ($1.67M total) on 2026-07-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a concrete datapoint on insider activity (size, price, and post-sale holdings) but does not include new fundamentals (earnings, guidance, litigation, or operational updates).
Market read
This is a fresh, primary-source insider-sale print that may slightly influence sentiment, but it is unlikely to drive a major repricing absent additional catalysts.
What to watch
Traders may overreact to insider sales; the key nuance is the 10b5-1 pre-arrangement, which often makes the timing less informative.
Background
The article is a SEC Form 4 insider transaction for Clover Health Investments, Corp./DE (CLOV), reported as an open-market sale by the CEO.
Ticker impact
Clover Health CEO Toy Andrew filed a Form 4 open-market sale of 313,476 shares at $5.3200 on 2026-07-01.
Likely limited, short-lived impact unless follow-on selling or plan details change.
The filing is primary-source and time-stamped, but it explicitly states a pre-arranged Rule 10b5-1 plan, which reduces interpretive weight versus discretionary selling.
Market effects
No direct sector read-through; this is company-specific insider transaction data.
None.
None.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity needs rather than bearish expectations.
Key entities
- issuerCLOVER HEALTH INVESTMENTS, CORP. /DE
Subject of the Form 4 insider transaction; CEO sale disclosed on 2026-07-01.
- insiderToy Andrew
Chief Executive Officer and director who sold 313,476 shares at $5.3200 under a 10b5-1 plan.
